Hypercalcemia in Patients with Parathyroid Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2023-12-08
FDA Approved: CINACALCET — Supplemental Application (Cipla USA Inc.)
FDA approved Cipla USA Inc.'s supplemental application for cinacalcet (generic) under ANDA 208915.